Treatment of Diabetes in the Mouse Model by Delphinidin and Cyanidin Hydrochloride in Free and Liposomal Forms

Abstract

Cyanidin and delphinidin are the main phenolic antioxidants in the grape (Vitis vinifera). The aim of this study was to investigate the in vitro and in vivo inhibitory effects of delphinidin and cyanidin chloride in the free and liposomal forms on the albumin glycation reaction. Delphinidin and cyanidin chlorides were encapsulated in the liposomes using an extrusion method. The rate of albumin glycation was evaluated using the ELISA method. Finally, in vivo anti-glycation of delphinidin and cyanidin chloride in the free and liposomal forms in diabetic mice was investigated. The encapsulation efficacies of delphinidin and cyanidin chloride in the liposomes were 89.05 % ± 0.18 and 85.00 % ± 0.15, respectively. In vitro treatment with 100 mg/mL delphinidin and cyanidin chloride in free forms could reduce the rate of albumin glycation to 30.50 ± 3.46 and 46.00 ± 2.50 %, respectively. Under identical conditions, the delphinidin and cyanidin chloride-loaded liposomes could reduce the rate of albumin glycation to 8.50 ± 2.10 and 14.60 ± 3.60 %, respectively. In vivo testing showed that anti-glycation activity of delphinidin and cyanidin in loaded forms was higher than in free forms. The daily administration of 100 mg/kg delphinidin chloride-loaded liposomes to diabetic mice at eight weeks could decrease the rate of albumin and HbA1c glycation to 46.35 ± 1.20 and 3.60 ± 0.25 %, respectively. Moreover, under identical conditions, the loaded liposomes with cyanidin chloride could decrease the rate of albumin and HbA1c glycation to 55.56 ± 1.32 and 4.95 ± 0.20 %, respectively. The findings showed that delphinidin and cyanidin chloride, in particular in the liposomal forms, could be used for treatment of diabetes mellitus complications.

Key words

Vitis vinifera - Vitaceae - albumin glycation - cyanidin chloride - delphinidin chloride - liposome

• References

• 1 Zheng CM, Ma WY, Wu CC, Lu KC. Glycated albumin in diabetic patients with chronic kidney disease. Clin Chim Acta 2012; 413: 1555-1561
• 2 Cozma AI, Sievenpiper JL, de Souza RJ, Chiavaroli L, Ha V, Wang DD, Mirrahimi A, Yu ME, Carleton AJ, Di Buono M, Jenkins AL, Leiter LA, Wolever TM, Beyene J, Kendall CW, Jenkins DJ. Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials. Diabet Care 2012; 35: 1611-1620
• 3 Rondeau P, Bourdon E. The glycation of albumin: structural and functional impacts. Biochimie 2011; 93: 645-658
• 4 Kappel VD, Pereira DF, Cazarolli LH, Guesser SM, da Silva CH, Schenkel EP, Reginatto FH, Silva FR. Short and long-term effects of Baccharis articulata on glucose homeostasis. Molecules 2012; 17: 6754-6768
• 5 Zunino S. Type 2 diabetes and glycemic response to grapes or grape products. J Nutr 2009; 139: 1794S-1800S
• 6 Yu W, Fu YC, Wang W. Cellular and molecular effects of resveratrol in health and disease. J Cell Biochem 2012; 113: 752-759
• 7 Kar P, Laight D, Shaw KM, Cummings MH. Flavonoid-rich grape seed extracts: a new approach in high cardiovascular risk patients?. Int J Clin Pract 2006; 60: 1484-1492
• 8 Peng N, Clark JT, Prasain J, Kim H, White CR, Wyss JM. Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005; 289: R771-R775
• 9 Fujii H, Yokozawa T, Kim YA, Tohda C, Nonaka G. Protective effect of grape seed polyphenols against high glucose-induced oxidative stress. Biosci Biotechnol Biochem 2006; 70: 2104-2111
• 10 Johnson MH, de Mejia EG, Fan J, Lila MA, Yousef GG. Anthocyanins and proanthocyanidins from blueberry-blackberry fermented beverages inhibit markers of inflammation in macrophages and carbohydrate-utilizing enzymes in vitro . Mol Nutr Food Res 2013; 57: 1182-1197
• 11 Bertuglia S, Malandrino S, Colantuoni A. Effects of the natural flavonoid delphinidin on diabetic microangiopathy. Arzneimittelforschung 1995; 45: 481-485
• 12 Lee SJ, Park WH, Park SD, Moon HI. Aldose reductase inhibitors from Litchi chinensis Sonn. J Enzyme Inhib Med Chem 2009; 24: 957-959
• 13 Gouranton E, Yazidi CE, Cardinault N, Amiot MJ, Borel P, Landrier JF. Purified low-density lipoprotein and bovine serum albumin efficiency to internalise lycopene into adipocytes. Food Chem Toxicol 2008; 46: 3832-3836
• 14 Youfang J, Fenghung C, Longhwang T, Linghuang Y. Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations. J Drug Targ 2005; 13: 19-27
• 15 Khosravi-Darani K, Mozafari MR. Nanoliposome potentials in nanotherapy: A concise overview. Int J Nanosci Nanotechnol 2010; 6: 3-13
• 16 Gharib A, Faezizadeh Z, Godarzee M. In vitro and in vivo activities of ticarcillin-loaded liposomes with different surface charges against Pseudomonas aeruginosa (ATCC 29248). Daru 2012; 20: 41-47
• 17 Gharib A, Faezizadeh Z, Mesbah-Namin SA. In vitro and in vivo antibacterial activities of cyanidinium chloride-loaded liposomes against a resistant strain of Pseudomonas aeruginosa . Planta Med 2013; 79: 15-19
• 18 Gharib A, Faezizadeh Z, Godarzee M. Therapeutic efficacy of epigallocatechin gallate-loaded liposomes against burn wound infection by methicillin-resistant Staphylococcus aureus . Skin Pharmacol Physiol 2013; 26: 68-75
• 19 Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 2006; 1: 297-315
• 20 Shaffa MW, Dayem SA, Elshemy WM. In vitro antibacterial activity of liposomal cephalexin against Staphylococcus aureus . Romanian J Biophys 2008; 18: 293-300
• 21 Padhye S, Chavan D, Pandey S, Deshpande J, Sawamy KV, Sarkar FH. Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry. Mini Rev Med Chem 2010; 10: 372-387
• 22 Tiwari AK, Rao JM. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Curr Sci 2002; 83: 30-38
• 23 Muqbil I, Masood A, Sarkar FH, Mohammad RM, Azmi AS. Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents. Cancers 2011; 3: 428-445
• 24 Fang JY, Hwang TL, Huang YL, Fang CL. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 2006; 310: 131-138
• 25 Stalmach A, Edwards CA, Wightman JD, Crozier A. Identification of (poly)phenolic compounds in concord grape juice and their metabolites in human plasma and urine after juice consumption. J Agric Food Chem 2011; 59: 9512-9522
• 26 Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4: 807-818
• 27 Chono S, Tauchi Y, Morimoto K. Pharmacokinetic analysis of the uptake of liposomes by macrophages and foam cells in vitro and their distribution to atherosclerotic lesions in mice. Drug Metab Pharmacokinet 2006; 21: 37-44
• 28 Ishida T, Harashima H, Kiwada H. Liposome clearance. Biosci Rep 2002; 22: 197-224
• 29 Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Alternat Med 2013; 2013: 1-33
• 30 Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Commission on Life Sciences National Research Council. Guide for the care and use of laboratory animals. Washington, D.C.: National Academy Press; 1996
• 31 ICH. Harmonized tripartite guideline. Validation of analytical procedures: text and methodology Q2 (R1). Available at http://www.ich.org/LOB/media/MEDIA417.pdf Accessed November 3, 2009.
• 32 Gharib A, Faezizadeh Z, Mohammad Asghari H. Preparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres. Daru 2011; 19: 351-355
• 33 Rubenstein DA, Maria Z, Yin W. Glycated albumin modulates endothelial cell thrombogenic and inflammatory responses. J Diabet Sci Technol 2011; 5: 703-713
• 34 Meeprom A, Sompong W, Chan CB, Adisakwattana S. Isoferulic acid, a new anti-glycation agent, inhibits fructose- and glucose-mediated protein glycation in vitro . Molecules 2013; 18: 6439-6454
• 35 Lin CY, Tsai SJ, Huang CS, Yin MC. Antiglycative effects of protocatechuic acid in the kidneys of diabetic mice. J Agric Food Chem 2011; 59: 5117-5124